首页> 外国专利> THERAPEUTIC AND PROPHYLACTIC AGENT FOR GLIOMA, BRAIN TUMOR MALIGNANCY MARKER, BRAIN TUMOR PROGNOSTIC MARKER, METHOD FOR DETERMINING MALIGNANCY AND PROGNOSIS OF BRAIN TUMOR AND ANTIBODY INHIBITING TUMOR PROLIFERATION

THERAPEUTIC AND PROPHYLACTIC AGENT FOR GLIOMA, BRAIN TUMOR MALIGNANCY MARKER, BRAIN TUMOR PROGNOSTIC MARKER, METHOD FOR DETERMINING MALIGNANCY AND PROGNOSIS OF BRAIN TUMOR AND ANTIBODY INHIBITING TUMOR PROLIFERATION

机译:胶质瘤治疗和预防剂,脑肿瘤恶性肿瘤,脑肿瘤预后标志物,测定脑肿瘤恶性肿瘤和抗体抑制肿瘤增殖的恶性和预后的方法

摘要

An object of the present invention is to provide a novel agent for treating or preventing a glioma, to provide a marker for malignancy of a brain tumor and a prognostic marker for a brain tumor, and to provide a method for determining malignancy of a brain tumor and a method for determining a prognosis for a brain tumor patient. According to the present invention, there are provided an agent for treating or preventing a glioma comprising an HVEM inhibitor as an active ingredient; a marker for malignancy of a brain tumor and a prognostic marker for a brain tumor, each comprising an HVEM protein or an HVEM gene; and a method for determining malignancy of a brain tumor and a method for determining a prognosis for a brain tumor patient, each comprising measuring an HVEM expression amount in a biological sample of a subject.
机译:本发明的目的是提供一种用于治疗或预防胶质瘤的新试剂,以提供用于脑肿瘤的恶性肿瘤和脑肿瘤的预后标志物的标志物,并提供一种确定脑肿瘤恶性肿瘤的方法 以及确定脑肿瘤患者预后的方法。 根据本发明,提供了用于治疗或预防包含HVEM抑制剂作为活性成分的胶质瘤的药剂; 脑肿瘤恶性肿瘤和脑肿瘤的预后标志物的标志物,各自包含HVEM蛋白或HVEM基因; 以及确定脑肿瘤恶性肿瘤的恶性肿瘤的方法及测定脑肿瘤患者的预后的方法,每种方法包括测量受试者的生物样品中的HVEM表达量。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号